Insider Selling: Aetna Inc. (AET) EVP Sells 10,288 Shares of Stock

Aetna Inc. (NYSE:AET) EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Aetna Inc. (NYSE:AET) traded down 3.08% on Tuesday, reaching $156.04. 3,191,307 shares of the company’s stock were exchanged. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $164.52. The firm has a 50-day moving average price of $157.45 and a 200-day moving average price of $145.52. The company has a market capitalization of $51.82 billion, a P/E ratio of 34.64 and a beta of 0.53.

Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter last year, the business earned $2.21 EPS. The business’s revenue was down 2.7% on a year-over-year basis. Equities research analysts expect that Aetna Inc. will post $9.55 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Aetna Inc. (AET) EVP Sells 10,288 Shares of Stock” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://www.chaffeybreeze.com/2017/09/19/insider-selling-aetna-inc-aet-evp-sells-10288-shares-of-stock.html.

Hedge funds have recently added to or reduced their stakes in the company. Bruderman Asset Management LLC acquired a new stake in shares of Aetna in the 2nd quarter worth $106,000. Liberty Capital Management Inc. lifted its stake in shares of Aetna by 206.9% in the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after acquiring an additional 629 shares during the period. Guardian Life Insurance Co. of America lifted its stake in shares of Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after acquiring an additional 9 shares during the period. Westside Investment Management Inc. lifted its stake in shares of Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after acquiring an additional 400 shares during the period. Finally, Phocas Financial Corp. acquired a new stake in shares of Aetna in the 2nd quarter worth $182,000. Institutional investors own 89.52% of the company’s stock.

Several equities research analysts have recently commented on AET shares. Royal Bank of Canada lifted their price objective on shares of Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, June 9th. BidaskClub downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Deutsche Bank AG lifted their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Morgan Stanley started coverage on shares of Aetna in a research note on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price objective for the company. Finally, Argus reiterated a “buy” rating and set a $165.00 price objective (up from $145.00) on shares of Aetna in a research note on Tuesday, May 30th. Seven analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $159.04.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply